MARTINELLI, Nicola
 Distribuzione geografica
Continente #
NA - Nord America 18.312
EU - Europa 14.109
AS - Asia 10.069
SA - Sud America 1.426
Continente sconosciuto - Info sul continente non disponibili 271
AF - Africa 235
OC - Oceania 24
Totale 44.446
Nazione #
US - Stati Uniti d'America 17.969
RU - Federazione Russa 5.066
SG - Singapore 4.179
GB - Regno Unito 3.138
CN - Cina 2.855
BR - Brasile 1.134
DE - Germania 1.121
IT - Italia 1.085
VN - Vietnam 888
HK - Hong Kong 807
FR - Francia 802
SE - Svezia 799
FI - Finlandia 741
IE - Irlanda 664
KR - Corea 335
UA - Ucraina 202
BD - Bangladesh 176
CA - Canada 171
JP - Giappone 142
IN - India 138
TR - Turchia 133
AR - Argentina 96
NL - Olanda 87
MX - Messico 77
BE - Belgio 75
ES - Italia 62
ID - Indonesia 62
NG - Nigeria 60
IQ - Iraq 59
PL - Polonia 55
ZA - Sudafrica 51
AT - Austria 44
CO - Colombia 44
EC - Ecuador 38
PK - Pakistan 36
UZ - Uzbekistan 35
CL - Cile 28
VE - Venezuela 27
TN - Tunisia 25
IL - Israele 23
MA - Marocco 23
SA - Arabia Saudita 23
AU - Australia 20
PE - Perù 20
CR - Costa Rica 18
GR - Grecia 18
EG - Egitto 17
JM - Giamaica 17
HN - Honduras 16
JO - Giordania 16
PH - Filippine 16
AE - Emirati Arabi Uniti 15
CH - Svizzera 15
DK - Danimarca 15
IR - Iran 15
PY - Paraguay 15
EU - Europa 14
KE - Kenya 14
HR - Croazia 13
LT - Lituania 13
UY - Uruguay 13
MY - Malesia 12
RO - Romania 12
AZ - Azerbaigian 11
KZ - Kazakistan 10
NP - Nepal 10
BJ - Benin 9
CZ - Repubblica Ceca 9
KG - Kirghizistan 9
AL - Albania 8
BO - Bolivia 8
OM - Oman 8
BG - Bulgaria 6
BH - Bahrain 6
DZ - Algeria 6
ET - Etiopia 6
LB - Libano 6
LV - Lettonia 6
PS - Palestinian Territory 6
PT - Portogallo 6
RS - Serbia 6
TH - Thailandia 6
BB - Barbados 5
BY - Bielorussia 5
GT - Guatemala 5
HU - Ungheria 5
LU - Lussemburgo 5
SN - Senegal 5
AM - Armenia 4
EE - Estonia 4
LK - Sri Lanka 4
MT - Malta 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
PA - Panama 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BZ - Belize 3
Totale 44.116
Città #
Southend 2.619
Singapore 2.297
Ashburn 2.019
Jacksonville 1.818
Chandler 1.644
Moscow 1.640
San Jose 1.637
Woodbridge 1.171
Dallas 1.163
Ann Arbor 858
Hong Kong 791
Council Bluffs 671
Dublin 657
Houston 571
Verona 520
The Dalles 453
Beijing 444
New York 383
Ho Chi Minh City 292
Lawrence 285
Princeton 285
Los Angeles 283
Wilmington 270
Nanjing 203
Helsinki 190
Hanoi 187
Jinan 185
Munich 170
Santa Clara 164
Buffalo 154
Boardman 149
São Paulo 146
Shenyang 134
Tokyo 116
Sindelfingen 111
Tianjin 98
Hebei 97
Redondo Beach 91
Columbus 89
Orem 87
Milan 86
Zhengzhou 81
Lancaster 77
Redmond 77
Brussels 75
Turku 75
Nanchang 73
Changsha 67
Haikou 56
Montreal 56
Jiaxing 55
Abuja 54
London 54
Dong Ket 53
San Francisco 53
Seattle 53
Toronto 52
Denver 50
Taiyuan 50
Frankfurt am Main 48
Phoenix 48
Ningbo 47
Chicago 46
Nürnberg 46
Washington 46
Hangzhou 44
Las Vegas 44
Norwalk 44
Seoul 44
Chennai 43
Guangzhou 43
Brooklyn 41
Warsaw 41
Atlanta 39
Boston 39
Manchester 38
Da Nang 37
Johannesburg 37
Stockholm 37
Taizhou 37
Haiphong 36
Amsterdam 35
Providence 35
Nuremberg 34
Rome 34
Lanzhou 32
Vienna 31
Mexico City 30
Tashkent 30
Rio de Janeiro 29
Poplar 28
Shanghai 27
Jakarta 26
Kent 26
Redwood City 26
Dongguan 25
Falkenstein 25
Baghdad 24
Brasília 23
Fuzhou 22
Totale 27.806
Nome #
Altered renal folate handling in hypertensive patients with nephroangiosclerotic damage 305
A 'desaturase hypothesis' for atherosclerosis: Janus-faced enzymes in omega-6 and omega-3 polyunsaturated fatty acid metabolism. 282
A score of risk factors associated with ischemic digital ulcers in patients affected by systemic sclerosis treated with iloprost 265
A relative ADAMTS13 deficiency supports the presence of a secondary microangiopathy in COVID 19 265
High plasma apolipoprotein C-III levels predict total and cardiovascular mortality in patients with angiographically defined coronary artery disease. 263
Apolipoprotein -CIII glycoforms correlate heterogeneously with plasma lipid profile in subjects with coronary artery disease 258
Global DNA hypomethylation in peripheral blood mononuclear cells as a biomarker of cancer risk 257
Anti-TNFalpha therapy in rheumatoid arthritis and autoimmunity 251
High plasma apolipoprotein C-III levels predict total and cardiovascular mortality in patients with angiographically defined coronary artery disease. 251
Associazione di polimorfismi del cluster dei geni FADS1 e FADS2 con i livelli di acidi grassi polinsaturi in malattie coronariche 248
ALOX5AP gene variants and risk of coronary artery disease: an angiography-based study 247
A1298C methylentetrahydrofolate reductase mutation and coronary artery disease:relationship with C677T polymorphysm and homocystein/folate metabolism 239
Promoter methylation in coagulation F7 gene influences plasma FVII concentrations and relates to coronary artery disease. 238
Activated factor VII-antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study 235
Novel serum paraoxonase activity assays are associated with coronary artery disease 231
Global DNA hypomethylation in peripheral blood mononuclear cells as a biomarker of cancer risk 229
NEXT GENERATION TARGETED DEEP SEQUENCING OF HEMOCHROMATOSIS GENES IN IRON OVERLOADED PATIENTS: A PILOT STUDY 227
Delta-5 and delta-6 desaturases: crucial enzymes in polyunsaturated fatty acid-related pathways with pleiotropic influences in health and disease 224
Comparison of Topical Tacrolimus 0.1% in pectin ointment with clobetasol 0.5% ointment in adults with moderate to severe in desquamative gingivitis:a 4-week, randomized, double-blind clinical trial 221
Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study. 220
A common polymorphism in low-density lipoprotein receptor gene is a predictor of factor VIII activity levels and is associated with coronary artery disease. 217
Analisi di 51 polimorfismi in 35 geni dell’infiammazione per la valutazione del rischio di coronaropatia e di infarto del miocardio 217
Tarrgeted Exome Sequencing of 5 Hemochromatosis Genes in Iron Overloaded Patients by Next Generation Sequencing (NGS) Platform. 215
Improvement of maternal and fetal outcomes in women with sickle cell disease treated with early prophylactic erythrocytapheresis 215
Identification of a novel serological marker in seronegative Rheumatoid Arthritis using the peptide library approach. 215
Combined effect of hemostatic gene polymorphisms and the risk of myocardial infarction in patients with advanced coronary atherosclerosis. 211
Additive effect of LRP8/APOER2 R952Q variant to APOE epsilon2/epsilon3/epsilon4 genotype in modulating apolipoprotein E concentration and the risk of myocardial infarction: a case-control study. 211
Serum levels of the hepcidin-20 isoform in a large general population: The Val Borbera study. 210
A decade of progress on the genetic basis of coronary artery disease. Practical insights for the internist 210
A common polymorphism in LDL-receptor gene is a predictor of factor VIII activity and is associated with coronary artery disease. 207
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study 205
Deep vein thrombosis in SARS-CoV-2 pneumonia-affected patients within standard care units: Exploring a submerged portion of the iceberg 205
Genetic risk score from GWA studies is strongly associated with angiographically-defined coronary artery disease, but not with mortalilty in the setting of secondary prevention. 203
Apolipoprotein C-III Strongly Correlates with Activated Factor VII-Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation 200
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population 199
Association of endogenous thrombin potential (ETP) with coronary artery disease. an angiography-based study. 199
Genomics of coronary artery disease and myocardial infarction. From Genome Wide Association Studies to the Next-Generation-Sequencing era 198
Anti-TNF? therapy in rheumatoid arthritis and autoimmunity 198
Apolipoprotein C-III glycoforms correlate heterogeneously with plasma lipid profile in subjects with coronary artery disease 197
Reply to Novelli 196
Interaction of antibodies against cytomegalovirus with heat-shock protein 60 in pathogenesis of atherosclerosis. 195
Air particulate matter and cardiovascular disease: a narrative review. 195
The -1131 T > C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study 195
Altered paraoxonase expression in patients with genetic haemochromatosis. 194
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study. 192
Efficacy of tacrolimus ointment in nickel sulphate allergic contact dermatitis 191
Hyperhomocysteinemia and Mortality after Coronary Artery Bypass Grafting 191
Comparative effect of tacrolimus 0.1% ointment and clobetasol 0.05% ointment in patients with oral lichen planus 191
PON2 Ser311Cys polymorphism is a predictor of total and cardiovascular mortality in patients with angiographically proven coronary artery disease. 191
Apolipoprotein C-III, n-3 Polyunsaturated Fatty Acids, and “Insulin-Resistant” T-455C APOC3 gene polymorphism in heart disease patients: example of gene-diet interaction 190
Apolipoprotein C-III predicts cardiovascular mortality in severe coronary artery disease and is associated with an enhanced plasma thrombin generation 190
Acute haemolysis by cold antibody during SARS-CoV-2 infection in a patient with Evans syndrome: a case report and literature review 190
Hyperhomocysteinemia in relation to total and cardiovascular death after coronary bypass grafting. 189
Increased Incidence of Ischemic Cerebrovascular Events in Cardiovascular Patients With Elevated Apolipoprotein CIII 189
Factor H interfers with the adhesion of sickle red cells to vascular endothelium: a novel disease modulating molecule 188
Hyperhomocysteinemia and mortality after coronary artery by-pass grafing. 186
Adults with moderate to severe clesquarnative gingivitis: A 4-week, randomized, single blind, clinical trial. Comparison of topical tacrolimus 0.1% in orabase with clobetasol 0.5% ointment 186
Determinants of serum ferritin and prevalence of iron overload in the Metabolic (Insulin Resistance). 186
[Genetic risk factors in ischemic cardiopathy] 186
A common polymorphism in low-density lipoprotein receptor gene is a predictor of factor VIII activity levels and is associated with coronary artery disease. 185
PON2 Ser311Cys polymorphism is a predictor of total and cardiovascular mortality in patients with angiographically confirmed coronary artery disease. 185
Serum uric acid, but not rs7442295 polymorphism of SCL2A9 gene, predicts total and cardiovascular mortality in severe coronary artery disease. 184
A1298C methylenetetrahydrofolate reductase mutation and coronary artery disease: Relationships with C677T polymorphism and homocysteine/folate metabolism 184
Low circulating vitamin B6 markers of inflammation, and risk of coronary artery disease. 183
Paraoxonase-1 status in patients with hereditary hemochromatosis 183
Interaction between metabolic syndrome and PON 1 polymorphism as a determinant of the risk of coronary artery disease 181
Comparative effect of tacrolimus 0.1% ointment and clobetasol 0.05% ointment in patients with oral lichen planus. 180
Interaction between folate and MTHFR1298 A/C polymorphism on Genomic DNA Methylation 179
Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk. 179
Low vitamin B6, markers of inflammation, and risk of coronary artery disease. 179
Detection of a large deletion in the P-selectin (SELP) gene 179
Determinants of serum ferritin in the metabolic syndrome. 178
High Plasma Levels of Activated Factor VII-Antithrombin Complex Point to Increased Tissue Factor Expression in Patients with SARS-CoV-2 Pneumonia: A Potential Link with COVID-19 Prothrombotic Diathesis 177
Homocysteine plasma concentration is related to severity of lung impairment in scleroderma. 177
Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS 177
Serum uric acid, but not rs7442295 polymorphism of SCL2A9 gene, predicts total and cardiovascular mortality in advanced coronary artery disease. 176
Interaction between smoking and PON2 Ser311 Cys polymorphism as a determinant of the risk of myocardial infarction 175
Interaction between PON 2 polymorphism Ser-Cys and smoking as a determinant of myocardial infarction risk 175
Basophil Blood Cell Count Is Associated With Enhanced Factor II Plasma Coagulant Activity and Increased Risk of Mortality in Patients With Stable Coronary Artery Disease: Not Only Neutrophils as Prognostic Marker in Ischemic Heart Disease 175
Proteomic analysis of urinary extracellular vesicles highlights specific signatures for patients with primary aldosteronism 174
Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatment 174
Clonal Hematopoiesis of Indeterminate Potential (CHIP) in Patients with Coronary Artery Disease and in Centenarians. Further Clues Linking Chip with Cardiovascular Risk 174
Detection of urinary exosomal HSD11B2 mRNA expression: a useful novel tool for the diagnostic approach of dysfunctional 11β-HSD2-related hypertension 174
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population. 173
PON2 Ser311Cys polymorphism is a predictor of total and cardiovascular mortality in patients with angiographically confirmed coronary artery disease. 172
Trace Elements Status and Metallothioneins DNA Methylation Influence Human Hepatocellular Carcinoma Survival Rate 172
High levels of homocysteine are associated with small number of traditional cardiovascular risk factors in patients with similar degree of coronary atherosclerosis. 171
Polymorphisms in the Hemostatic Pathway Genes and the Risk of Myocardial infarction in Patients with Advanced Coronary Artery Disease. Results from the Verona Heart Project. 171
Factor VIII:c Levels in Subjects with the Factor V R2 Polymorphism. 171
Carriership of apolipoprotein CIII –455C gene variant strongly increases the coronary artery disease risk associated with the metabolic sindrome. 171
Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease 170
Not Just Arterial Damage: Increased Incidence of Venous Thromboembolic Events in Cardiovascular Patients With Elevated Plasma Levels of Apolipoprotein CIII 170
Double-blind placebo-controlled challange with nickle salts in patients affected by recurrent aphtous stomatitis 169
Nichel sulphate intollerance in oral lichen planus 169
Genetic and environmental determinants of hyperhomocysteinemia in subjects with angiographically proven coronary artery disease 169
Increased plasma thrombin potential is associated with stable coronary artery disease: An angiographically-controlled study 169
A dangerous onychodystrophy 169
ApoE epsilon 2/epsilon 3/epsilon 4 polymorphism, ApoC-III/ApoE ratio and metabolic syndrome 168
Prevalence of body iron excess in the metabolic syndrome. 167
SNPs of the FADS gene cluster are associated with polyunsaturated fatty acids in a cohort of patients with cardiovascular disease 167
Totale 19.874
Categoria #
all - tutte 149.249
article - articoli 95.593
book - libri 0
conference - conferenze 52.632
curatela - curatele 0
other - altro 399
patent - brevetti 0
selected - selezionate 0
volume - volumi 625
Totale 298.498


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.361 0 0 0 168 101 72 29 107 93 66 201 524
2022/20234.630 350 422 486 790 459 1.050 37 306 540 29 96 65
2023/20242.408 98 169 191 237 286 469 69 192 17 80 363 237
2024/20255.663 314 410 175 956 244 201 293 222 805 331 489 1.223
2025/202616.915 1.258 854 1.230 2.799 4.269 1.169 1.506 847 1.343 877 276 487
2026/20272.282 202 486 809 785 0 0 0 0 0 0 0 0
Totale 44.446